New device demonstrates 83% microbial inactivation to combat airborne pathogens, suggesting improved air safety.
The persistent challenge of airborne pathogens in densely populated indoor environments calls for efficient and reliable air sterilization solutions. This study presents a compact three-electrode Double Dielectric Barrier Discharge (DDBD) plasma module for sterilizing contaminated airflow, achieving up to 83% microbial inactivation at 9.3 kV and 10.3 kHz. While effective, the plasma discharge produced reactive byproducts, notably ozone (up to 46.21 ppm) and nitrogen oxides (NOₓ), at levels exceeding health-based safety thresholds. To mitigate these emissions, a four-stage byproduct control strategy was developed, including a MnO₂ catalytic mesh for ozone decomposition, a UV-activated TiO₂ photocatalytic stage for NOₓ reduction and enhanced sterilization, an upgraded 15 mm activated carbon bed for residual adsorption of NOₓ and volatile organic compounds, and a feedback-controlled electrochemical sensor to monitor byproduct levels and dynamically adjust plasma power. The modular design facilitates integration into existing filtration frameworks, providing a scalable and practical solution for indoor air treatment in high-traffic settings such as hospitals, schools, and transport hubs.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: